https://www.selleckchem.com/products/smi-4a.html
During the current SARS-CoV-2 pandemic it is important to identify risk factors for COVID-19. Registry studies are providing growing evidence on the elevated risk of mortality from COVID-19 in patients with chronic liver disease, especially in advanced stages. Results may, however, have a selection bias towards severe cases. Limited data is available on COVID-19 in patients with autoimmune liver disease (AILD). To perform an online survey to capture the prevalence of COVID-19 and the state of medical care of patients with AILD in Europe
Like
Comment
Share
